Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Avastin and Tarceva for Upper Gastrointestinal Cancers
This study has been completed.
Study NCT00350753 Information provided by Rigshospitalet, Denmark
First Received on July 10, 2006. Last Updated on July 14, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cholangiocarcinoma
Gallbladder Cancer
Additional conditions recognized in this trial
Gallbladder Neoplasms
Gastrointestinal Neoplasms
More general conditions related to this trial
Adenocarcinoma
Biliary Tract Diseases
Biliary Tract Neoplasms
Carcinoma
Digestive System Diseases
Digestive System Neoplasms
Gallbladder Diseases
Gastrointestinal Diseases
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Interventions listed in this trial
Erlotinib and bevacizumab
Additional drug interventions recognized in this trial
Bevacizumab
Erlotinib
More general drug interventions related to this trial
Angiogenesis Inhibitors
Angiogenesis Modulating Agents
Antineoplastic Agents
Enzyme Inhibitors
Growth Inhibitors
Growth Substances
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protein Kinase Inhibitors
Therapeutic Uses
Sponsors listed in this trial
Rigshospitalet, Denmark
Aarhus University Hospital
Back to top of Main Content
